Over the past couple of weeks, users on the r/alexa subreddit have reported getting automatically upgraded to Alexa Plus as a ...

Remember the torture memos? The boat strike memos may be worse. 'Taylor Swift is a Nazi' narrative boosted by coordinated online effort, new report finds Thousands issued urgent flood warning: "Move ...

Ashley traded the quiet life of a small town in a big house for the hustle and bustle of the Windy City. On any given day you might find her working on a freelance photo or blogging gig, wrangling her ...

Does anyone know if there are any tutorials or documentation for the LilyGo T-Display S3 AMOLED Plus? I tried to decypher the examples they have but I can't make any sense of it. I tried the examples ...

Findings showed Zepzelca with atezolizumab reduced the risk of disease progression or death by 46% and the risk of death by 27% vs atezolizumab alone. The approval was based on data from the ...

Dick Cheney cause of death: Former VP dies at 84 ‘Predator: Badlands’ early reviews are all leaning one way Trump could be handing the Virginia governor's race to Democrats If You See a Star on a Barn ...

Basel, 3 October 2025 - Roche (SIX: RO, ROG; OTCQX: RHHBY) announced today that the U.S. Food and Drug Administration (FDA) has approved Tecentriq® (atezolizumab) and Tecentriq Hybreza® (atezolizumab ...

Automotive and transportation tutorials on car maintenance are a reality in the automotive and transportation sector, as they attract audiences on their websites, channels, and automotive forums, ...

The OVARIO trial supports niraparib plus bevacizumab as feasible maintenance therapy in advanced ovarian cancer post-platinum chemotherapy, with consistent long-term results. Median PFS was 19.6 ...

aDepartment of Medical Oncology, Hospital Universitario 12 de Octubre, H12O-CNIO Lung Cancer Unit, Universidad Complutense and Ciberonc, Madrid, Spain bDepartment of Hematology and Oncology, Fox Chase ...

The IMforte trial showed improved progression-free survival and overall survival with lurbinectedin plus atezolizumab in extensive-stage small cell lung cancer. The trial's primary analysis results ...